Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-density-lipoprotein (LDL) Cholesterol”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01380730
What this trial is testing

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Who this might be right for
Hyperlipidemia
Amgen 631
Large-scale testing (Phase 3)Not Yet RecruitingNCT07619118
What this trial is testing

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

Who this might be right for
Hypercholesterolaemia
AstraZeneca 200
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Not applicableStudy completedNCT01200160
What this trial is testing

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Who this might be right for
Cardiovascular Diseases
Abbott 128
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Not applicableStudy completedNCT07748559
What this trial is testing

Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá

Who this might be right for
Insulinemic ResponseType 2 Diabetes (Adult Onset)Hyperglycaemia (Diabetic)+1 more
Ruby Alejandra Villamil 52
Early research (Phase 1)Study completedNCT04774003
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Who this might be right for
Hyperlipidemia
Novartis Pharmaceuticals 40
Early research (Phase 1)Looking for participantsNCT06164730
What this trial is testing

VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease
Verve Therapeutics, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT07218900
What this trial is testing

Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

Who this might be right for
Dyslipidaemia
AstraZeneca 76
Large-scale testing (Phase 3)Study completedNCT03400800
What this trial is testing

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDRisk Factor, CardiovascularElevated Cholesterol
The Medicines Company 1,617
Not applicableStudy completedNCT05628259
What this trial is testing

The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT

Who this might be right for
Type2 DiabetesSelf EfficacySelf Management+5 more
Pamukkale University 70
Not applicableStudy completedNCT03648112
What this trial is testing

Effects of Beta-glucan From Barley and Oats on Glucose and Lipid Metabolism, and Satiety

Who this might be right for
Lipid MetabolismGlucose MetabolismSatiety
University of Jena 32
Not applicableStudy completedNCT07382778
What this trial is testing

Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

Who this might be right for
Hypercholesterolemia
JW Pharmaceutical 1,538
Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Large-scale testing (Phase 3)Study completedNCT00050479
What this trial is testing

Laser and Medical Treatment of Diabetic Macular Edema

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750341
What this trial is testing

Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 156
Not applicableLooking for participantsNCT07675603
What this trial is testing

Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability

Who this might be right for
Healthy
University of Bath 20
Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Testing effectiveness (Phase 2)Study completedNCT06692764
What this trial is testing

Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Who this might be right for
Atherosclerotic Cardiovascular Disease
AstraZeneca 202
Next Page